Biography
Paul Campbell has significant experience in the cleantech and life sciences sectors. His investment scope focuses primarily on cleantech opportunities, with a particular focus on industrial biotechnology.
Prior to joining DFJ Mercury, Mr. Campbell co-founded and was President of Aster Bio, a Houston-based biotechnology company that provides bacteria and bacterial blends for the bioremediation, wastewater, and agricultural industries. Also an active member of the life sciences entrepreneurial eco-system, Mr. Campbell interned at the Houston Technology Center (HTC) where he helped start-up companies define business and operational strategies and develop and refine investor presentations and business plans. In addition, he currently sits on the HTC Life Sciences Screening Committee.
Mr. Campbell received his B.S. from Duke University, and earned a Ph.D. in Biochemistry and Cell Biology from Rice University, and a Master of Business Administration from the Jones Graduate School of Management at Rice University.
